Dr. Mehrdad Mark Mofid, MD

Dr. Mofid practices at Umansky Medical Management, Inc. in La Jolla, California.

Dr. Mofid's NPI, 1225244155, was assigned on May 15, 2007. Dr. Mofid graduated from The Johns Hopkins University School of Medicine in 1997. Dr. Mofid holds California license A83432.

Dr. Mofid's primary practice is Umansky Medical Management, Inc., at 4150 Regents Park Row, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 550-9697.

Dr. Mofid's primary practice is Umansky Medical Management, Inc. in La Jolla, California. Dr. Mofid is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Mofid to 2 more hospitals, 2 group practices and clinics, 2 medical groups, 1 physician office and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mofid practices, 7 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Mofid's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Mofid is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Mofid's licenses on file in 2 states: California and Maryland.

Dmand AI lists breast reconstruction, head wound, minor head injury and removal of damaged skin or skin graft among the conditions Dr. Mofid treats.

CMS data shows 88 Medicare services from Dr. Mofid across 4 procedure codes in 2024, for 69 Medicare patients. Medicare paid $10,003 for them.

CMS counts 69 Medicare patients who saw Dr. Mofid in 2024. The largest group is 65 to 74, with 37 patients. 70% of them have high blood pressure, and 67% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mofid's median patient age at 55, with 73% women.

In 2024, Dr. Mofid wrote 235 Medicare Part D claims for 66 patients. 98% of them were for generic drugs. CMS names the drug for 170 of them, across 3 drugs with 11 or more claims each, at $834 in total drug cost. In 2023, CMS named 169 claims across 4 drugs.

Dr. Mofid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mofid as offering telehealth.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mofid, published from 2012 to 2024. The most frequent topics are Buttocks, Plastic Surgery Procedures and Prostheses and Implants. Dr. Mofid has published most often in Plast Reconstr Surg. Dr. Mofid's most frequent co-authors are James J. Chao, MD, Constantino Gilberto Mendieta, MD and Omar M. Kadri, MD.

CMS Open Payments shows 243 general payments to Dr. Mofid from 42 drug and device companies from 2016 to 2025. Gifts make up the largest share, 38% of the total. Allergan Inc. paid the most, $37,767. It also lists 7 research payments totaling $15,404 from 2016 to 2019.

Dmand AI lists 1 award for Dr. Mofid.

Dr. Mofid graduated from The Johns Hopkins University School of Medicine in 1997.

Dr. Mofid is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.